This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sluis-Cremer, N.
Right arrow Articles by Mellors, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sluis-Cremer, N.
Right arrow Articles by Mellors, J. W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2007, p. 48-53, Vol. 51, No. 1
0066-4804/07/$08.00+0     doi:10.1128/AAC.00683-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Molecular Mechanism by Which the K70E Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Nucleoside Reverse Transcriptase Inhibitors{triangledown}

Nicolas Sluis-Cremer,* Chih-Wei Sheen, Shannon Zelina, Pedro S. Argoti Torres, Urvi M. Parikh, and John W. Mellors

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Received 2 June 2006/ Returned for modification 25 July 2006/ Accepted 23 October 2006

The K70E mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) has become more prevalent in clinical samples, particularly in isolates derived from patients for whom triple-nucleoside regimens that include tenofovir (TNV), abacavir, and lamivudine (3TC) failed. To elucidate the molecular mechanism by which this mutation confers resistance to these nucleoside RT inhibitors (NRTI), we conducted detailed biochemical analyses comparing wild-type (WT), K70E, and K65R HIV-1 RT. Pre-steady-state kinetic experiments demonstrate that the K70E mutation in HIV-1 RT allows the enzyme to discriminate between the natural deoxynucleoside triphosphate substrate and the NRTI triphosphate (NRTI-TP). Compared to the WT enzyme, K70E RT showed 2.1-, 2.3-, and 3.5-fold-higher levels of resistance toward TNV-diphosphate, carbovir-TP, and 3TC-TP, respectively. By comparison, K65R RT demonstrated 12.4-, 12.0-, and 13.1-fold-higher levels of resistance, respectively, toward the same analogs. NRTI-TP discrimination by the K70E (and K65R) mutation was primarily due to decreased rates of NRTI-TP incorporation and not to changes in analog binding affinity. The K65R and K70E mutations also profoundly impaired the ability of RT to excise 3'-azido-2',3'-dideoxythymidine monophosphate (AZT-MP) and other NRTI-MP from the 3' end of a chain-terminated primer. When introduced into an enzyme with the thymidine analog mutations (TAMs) M41L, L210W, and T215Y, the K70E mutation inhibited ATP-mediated excision of AZT-MP. Taken together, these findings indicate that the K70E mutation, like the K65R mutation, reduces susceptibility to NRTI by selectively decreasing NRTI-TP incorporation and is antagonistic to TAM-mediated nucleotide excision.

* Corresponding author. Mailing address: Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, S817 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261. Phone: (412) 648-8457. Fax: (412) 648-8521. E-mail: CremerN{at}dom.pitt.edu.

{triangledown} Published ahead of print on 6 November 2006.

Antimicrobial Agents and Chemotherapy, January 2007, p. 48-53, Vol. 51, No. 1
0066-4804/07/$08.00+0     doi:10.1128/AAC.00683-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Tchesnokov, E. P., Obikhod, A., Massud, I., Lisco, A., Vanpouille, C., Brichacek, B., Balzarini, J., McGuigan, C., Derudas, M., Margolis, L., Schinazi, R. F., Gotte, M. (2009). Mechanisms Associated with HIV-1 Resistance to Acyclovir by the V75I Mutation in Reverse Transcriptase. J. Biol. Chem. 284: 21496-21504 [Abstract] [Full Text]  
  • Ehteshami, M., Scarth, B. J., Tchesnokov, E. P., Dash, C., Le Grice, S. F. J., Hallenberger, S., Jochmans, D., Gotte, M. (2008). Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against "Nucleotide-competing Reverse Transcriptase Inhibitors". J. Biol. Chem. 283: 29904-29911 [Abstract] [Full Text]  
  • Hachiya, A., Kodama, E. N., Sarafianos, S. G., Schuckmann, M. M., Sakagami, Y., Matsuoka, M., Takiguchi, M., Gatanaga, H., Oka, S. (2008). Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors. J. Virol. 82: 3261-3270 [Abstract] [Full Text]  
  • Radzio, J., Sluis-Cremer, N. (2008). Efavirenz Accelerates HIV-1 Reverse Transcriptase Ribonuclease H Cleavage, Leading to Diminished Zidovudine Excision. Mol. Pharmacol. 73: 601-606 [Abstract] [Full Text]  
  • Zelina, S., Sheen, C.-W., Radzio, J., Mellors, J. W., Sluis-Cremer, N. (2008). Mechanisms by Which the G333D Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Facilitates Dual Resistance to Zidovudine and Lamivudine. Antimicrob. Agents Chemother. 52: 157-163 [Abstract] [Full Text]  
  • Bradshaw, D., Malik, S., Booth, C., Van Houtte, M., Pattery, T., Waters, A., Ainsworth, J., Geretti, A. M. (2007). Novel Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Antimicrob. Agents Chemother. 51: 4489-4491 [Abstract] [Full Text]  
  • Brehm, J. H., Koontz, D., Meteer, J. D., Pathak, V., Sluis-Cremer, N., Mellors, J. W. (2007). Selection of Mutations in the Connection and RNase H Domains of Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Increase Resistance to 3'-Azido-3'-Dideoxythymidine. J. Virol. 81: 7852-7859 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»